Aceto has acquired A&C to expand biomanufacturing offerings

By The Science Advisory Board staff writers

April 16, 2021 -- Aceto has acquired A&C, a global good manufacturing practice (GMP) manufacturer of specialty excipients, buffers, and process solutions.

The acquisition will increase Aceto's GMP manufacturing, packaging, and ingredients offerings for the cell culture, vaccine, and biopharmaceutical industries. A&C has capabilities in custom ingredient development, manufacturing, and packaging in the life sciences industries, which will now provide Aceto with greater access to critical raw materials and excipients used in synthesizing biologics.

Aceto will continue to support A&C's manufacturing facilities and offices in the U.S., Canada, and Ireland. Financial terms of the acquisition were not disclosed.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.